Research

Kang Li , Ph.D., Head of Biologics

Kang Li , Ph.D.

Head of Biologics

  • Former Executive Director, Pfizer-CrownBio Asian Cancer Research Center, Crown Bioscience
  • Senior Principle Scientist, Group and Project Leader, Pfizer-La Jolla Laboratory, Oncology Research Unit
  • Senior Scientist, Tanox (acquired by Genentech)
  • Post-Doctoral and Assistant Professor, UTSW Medical Center at Dallas
  • Ph.D. in Biochemistry and Molecular Biology from Emory University
  • M.S. in Cell Biology and Genetics, Wuhan University
  • M.B.A., University of Dallas
Lusong Luo, Ph.D., Head of Discovery Biology

Lusong Luo, Ph.D.

Head of Discovery Biology

  • More than 12 years of pharmaceutical industry experience
  • Former Senior Director of Discovery Biology at BioDuro where he built and managed a team of over 40 scientists
  • Group Manager in Oncology Discovery at GlaxoSmithKline; also held roles of Research Investigator and Principal Scientist
  • Post-Doctoral with Christopher Walsh, Harvard Medical School, Department of Biological Chemistry and Molecular Pharmacology
  • Ph.D. from University of New Mexico
  • B.S. from Fudan University, Shanghai
Lai Wang, Ph.D. Head of Discovery Biomarkers & In Vivo Pharmacology

Lai Wang, Ph.D.

Head of Discovery Biomarkers & In Vivo Pharmacology

  • Former Director of Research at Joyant Pharmaceuticals, where he led a multidisciplinary team working on preclinical oncology programs
  • Post-doc with Xiaodong Wang at Howard Hughes Medical Institute
  • Ph.D. from University of Texas Health Science Center at San Antonio
  • B.S. from Fudan University in 1996
Zhiwei Wang

Zhiwei Wang, Ph.D.

Research Head of Chemistry

  • More than 10 years of biotech and pharmaceutical industry experience
  • Former Associate Director of Medicinal Chemistry at BioDuro where he managed a team of over 20 scientists providing integrated drug discovery service for big pharmaceuticals
  • Research Investigator at Genomics Institute of the Novartis Research Foundation (GNF)
  • Senior Scientist at ISIS Pharmaceuticals
  • Post-Doctoral with Professor Carmelo Rizzo at Vanderbilt University
  • Ph.D. in organic chemistry, M.S. and B.S. from Lanzhou University
Min Wei, Ph.D., Head of Molecular Sciences

Min Wei, Ph.D.

Head of Molecular Sciences

  • More than 12 years of pharmaceutical R&D experience
  • Former Associate Director of Discovery Biology at BioDuro where she managed a team of over 20 scientists
  • Research Investigator in Cardiovascular and Urology Biology at GlaxoSmithKline
  • Senior Investigator in High Throughput Screening at Incyte
  • Post-Doctoral with Professor Steve Lippard at Massachusetts Institute of Technology
  • Ph.D. from University of New Mexico, B.S. from Tsinghua University, Beijing
Steven Young, Ph.D.

Steven Young, Ph.D.

Acting Head of Medicinal Chemistry

  • 28 years of medicinal chemistry pharmaceutical R&D experience
  • Led chemistry research teams that delivered the widely prescribed HIV drugs efavirenz and raltegravir to AIDS patients
  • Former VP and Head of Medicinal Chemistry at Merck’s West Point laboratory
  • Delivered numerous compounds across a wide range of therapeutic areas into Phase I, II and III clinical programs
  • Ph.D. in Organic Chemistry from the University of California at Berkeley
  • B.S. from Stevens Institute of Technology
Changyou Zhou

Changyou Zhou, Ph.D.

Executive Head of Chemistry

  • Former Senior Director of Medicinal Chemistry at BioDuro where he built and managed team of over 50 scientists
  • Senior Research Fellow in Medicinal Chemistry at Merck
  • Post-Doctoral with Professor Martin J. O’Donnell, Indiana University-Purdue University
  • Ph.D. with late Professor Wolfgang Oppolzer, University of Geneva, Switzerland
  • M.S. from Chendu Institute of Organic Chemistry
  • B.S. from Lanzhou University